Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Mesenchymal Cell Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Mesenchymal Cell Neoplasm

Cancer Family

Mesenchymal Cell Neoplasm

CI-CAN-00000027Explore in graph →

Non-malignant413 active trials10 approved drugs208 evidence items

NCIt: C7059

Overview
Statistics
Survival
Genomics12
Variants & evidence208
Drugs20
Trials1848
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (108)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 51–75 of 108 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues.
· Am J Clin Pathol · 2001 · PMID 11242790 · validated civic_curation pubmed
Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
· Br J Dermatol · 2022 · PMID 35441365 · validated civic_curation pubmed
Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma.
· Virchows Arch · 2020 · PMID 31768625 · validated civic_curation pubmed
In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
· Clin Cancer Res · 2017 · PMID 28939748 · validated civic_curation pubmed
Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
· Am J Surg Pathol · 2006 · PMID 16931951 · validated civic_curation pubmed
A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.
· Mod Pathol · 2020 · PMID 31383960 · validated civic_curation pubmed
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.
· J Clin Oncol · 2025 · PMID 39836945 · validated

Showing 51–75 of 108 publications

← Previous
1
2
3
4
5
Next →

civic_curation

Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.

· Eur J Cancer · 2022 · PMID 35452896 · validated civic_curation pubmed

Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.

· Oncotarget · 2016 · PMID 26894859 · validated civic_curation pubmed

Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.

· J Clin Oncol · 2012 · PMID 22614970 · validated civic_curation pubmed

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

· Lancet · 2013 · PMID 23177515 · validated civic_curation pubmed

Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review.

· Sarcoma · 2015 · PMID 26146478 · validated civic_curation pubmed

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

· N Engl J Med · 2010 · PMID 20979472 · validated civic_curation pubmed

Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.

· Cancer Res · 1999 · PMID 10383129 · validated civic_curation pubmed

Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.

· Am J Surg Pathol · 2019 · PMID 30720533 · validated civic_curation pubmed

Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.

· Histopathology · 2018 · PMID 29758589 · validated civic_curation pubmed

Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma.

· Genes Chromosomes Cancer · 2024 · PMID 39302072 · validated civic_curation pubmed

Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.

· Mod Pathol · 2023 · PMID 37422156 · validated civic_curation pubmed

Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.

· Cancer Med · 2020 · PMID 32087612 · validated civic_curation pubmed

The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers.

· Cancer Res · 2010 · PMID 21030459 · validated civic_curation pubmed

Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.

· Cancer Discov · 2014 · PMID 24875859 · validated civic_curation pubmed

Fusion of the EWS and CHOP genes in myxoid liposarcoma.

· Oncogene · 1996 · PMID 8637704 · validated civic_curation pubmed

Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal Tumor.

· Case Rep Oncol · 2011 · PMID 22114577 · validated civic_curation pubmed

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.

· Cancer · 2018 · PMID 30204247 · validated civic_curation pubmed

A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure.

· Onco Targets Ther · 2018 · PMID 29760553 · validated civic_curation pubmed